Next Talk
The Importance of Viral Clearance and Characterization in Gene Therapy Products
It is a regulatory requirement (ICH Q5A Revision 2) to demonstrate viral safety of biotechnology product derived from in vitro cell culture, including viral-vector derived products like recombinant Adeno-Associated virus used as a delivery medium for gene therapy products. Viral clearance in gene therapy product poses different challenges from the other non-viral biotechnology product in…
Upcoming Talks
On-demand Talks
Related topics: